Thaddeus Tolleson, MD, Cardiology, Tyler, TX

ThaddeusRexTollesonMDFACC FSCAI

Cardiology Tyler, TX

Interventional Cardiology, Peripheral Endovascular Interventional Cardiology, Vascular Medicine

Chief of Cardiology - Univ. of Texas Health East Texas Director of research- Tyler CVC

Dr. Tolleson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tolleson's full profile

Already have an account?

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Interventional Cardiology, 2001 - 2002
  • Duke University Hospital
    Duke University HospitalFellowship, Cardiovascular Disease, 1997 - 2001
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolResidency, Internal Medicine, 1993 - 1997
  • University of Texas Medical School
    University of Texas Medical SchoolClass of 1993
  • Texas A&M University
    Texas A&M UniversityBS, Microbiology, Dean's List, Academic Excellence Award, Distinguished Student Award, 1985 - 1989

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2001 - 2021
  • TX State Medical License
    TX State Medical License 1994 - 2022
  • American Board of Internal Medicine Cardiovascular Disease
  • National Board of Physicians and Surgeons Cardiovascular Disease
  • National Board of Physicians and Surgeons Internal Medicine
  • National Board of Physicians and Surgeons Interventional Cardiology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
  • Richard A. Schatz Fellowship Award for Interventional Cardiology Duke University Medical Center, 2000
  • Robert H. Peter Interventional Fellow Award Duke University Medical Center, 1999
  • Join now to see all

Clinical Trials

Publications & Presentations


Journal Articles

  • Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries: The RESOLUTE US Clinical...  
    Alan C. Yeung, Martin B. Leon, Ash Jain, Thaddeus R. Tolleson, Douglas J. Spriggs, Brent T. McLaurin, Jeffrey J. Popma, Peter J. Fitzgerald, Donald E. Cutlip,Joseph M...., J Am Coll Cardiol, 4/4/2011
  • Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials)  
    Tolleson TR, Newby LK, Harrington RA, Bhapkar MV, Verheugt FW, Berger PB, Moliterno DJ, White HD, Ohman EM, Van de Werf F, Topol EJ, Califf RM, SYMPHONY and the 2nd SY..., Am J Cardiol, 8/1/2003
  • Relationship Between Heparin Anticoagulation and Clinical Outcomes in Coronary Stent Intervention: The ESPRIT Trial  
    Tolleson TR, O'Shea JC, Tcheng JE., Journal of the American College of Cardiology, 1/1/2003
  • Join now to see all

Books/Book Chapters


  • Comparison of Measurement of Platelet Aggregation of Aggrastat, Reopro and Eptifibatide (The COMPARE study)
    Batchelor WA, Tolleson TR, Harrington RA, European Society of Cardiology, 5/1/2000


  • Anticoagulation Strategies in Acute Coronary Syndromes 
    ACC/I2 Interventional Summit 2006 New York, NY - 1/1/2006
  • Evolution of Anticoagulation in PCI 
    The Medicine Co. National Training Seminar New York, NY - 1/1/2005
  • Stent Thrombosis in Patients Undergoing PCI after Presenting with an Acute Coronary Syndrome 
    European Society of Cardiology-Stockholm, Sweden - 1/1/2001
  • Join now to see all


  • Protective Effects of Glycoprotein IIb/IIIa Inhibitors in Patients with non-ST elevation Myocardial Infarction 
    Tolleson TR, Cor Therapeutics, Inc

Professional Memberships